FDA approves higher dose of Wegovy

The Food and Drug Administration (FDA) connected Thursday approved a higher dose of the Wegovy value nonaccomplishment drug. The manufacturer, Novo Nordisk, accrued the semaglutide injection by 4.8 mg to full 7.2 mg. The institution says the higher dosage is recommended for those who taken the little dose already for astatine slightest 4 weeks. Novo Nordisk…